3D Systems’ stock fell 36.7% after earnings, signaling that investors were not reassured by management’s growth narrative. The transcript highlights a key concern: aerospace and defense growth is exposed to program timing, which management said could make quarterly results lumpier; it does not provide enough financial detail here to identify a more specific earnings or guidance disappointment.
- Management reported year-over-year revenue growth at double-digit rates excluding the impact of 2025 enterprise software divestitures, expanded gross margins, lower operating expenses, and positive Adjusted EBITDA; the transcript excerpt gives no supporting figures.
- Aerospace and defense revenue grew more than 50% excluding the Air Force development program, led by printer sales, but management cautioned that defense program timing may make quarterly results lumpier.
- Medical technology continued to grow, with demand for orthopedic implants supporting parts revenue and printer sales; the company is expanding production capacity.
- Dental material revenue recovered as aligner volumes returned to their longer-term run rate, while adoption of denture printing technology continued to rise.
- Semiconductor and high-performance computing revenue grew significantly, and customers added printer capacity; management expects this area to become a material revenue stream over time.
Community Discussion